Find News

Filter articles

Applied Filters

Showing 1 to 10 of 828 results

India approves COVID-19 vaccines ahead of huge rollout

India05-01-2021Muireann Bolger

India has granted emergency approval to COVID-19 vaccines developed by AstraZeneca and Oxford University and one from the state-run institute Bharat Biotech, ahead of a huge immunisation drive that is planned to begin this week.

Canopy sues GW Pharma over cannabis patent

Canada, US24-12-2020Muireann Bolger

Canadian medical cannabis company Canopy Growth has accused GW Pharma of using a patented technological process to produce its flagship epilepsy treatment, Epidiolex, without authorisation.

Ex-DuPont employee gets 42 months over trade secret theft

24-12-2020Rory O'Neill

A US federal appeals court has upheld a 42-month prison sentence for an ex-employee of DuPont Industrial Biosciences who stole trade secrets from the firm.

Danish university sues Creative Biolabs over ‘antibody pirating’

Denmark, US09-12-2020Sarah Morgan

The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5. 

CMA reveals antitrust investigation into Essential Pharma over bipolar drug

UK30-11-2020Muireann Bolger

The UK Competition and Markets Authority is investigating Essential Pharma over suspicions that the pharmaceutical company contravened competition law by proposing to withdraw the supply of Priadel, a lithium-based medication for bipolar disease.

Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen


Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen.

Generics sign patent pool pledge to improve access to COVID-19 treatments

International17-11-2020Muireann Bolger

In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences.

FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent


The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.

EC signs contract with Pfizer to access watershed vaccine

EU12-11-2020Muireann Bolger

The European Commission has approved a fourth contract with pharmaceutical companies Pfizer and BioNTech, following their revelation that they had developed a vaccine that could potentially prevent more than 90% of people from becoming infected by COVID-19.

Novavax seals COVID-19 vaccine deal with Australia

Australia05-11-2020Rory O'Neill

Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.

Showing 1 to 10 of 828 results